96
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Functional respiratory imaging: heterogeneity of acute exacerbations of COPD

, , , , , , , , & show all
Pages 1783-1792 | Published online: 30 May 2018

References

  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management and Prevention of COPD2016 Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/Accessed September 25, 2017
  • LeidyNKWilcoxTKJonesPWStandardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diaryAm J Respir Crit Care Med2011183332332920813886
  • KocksJWvan den BergJWKerstjensHADay-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2013827328623766644
  • AaronSDManagement and prevention of exacerbations of COPDBMJ2014349g523725245156
  • ParkerCMVoducNAaronSDWebbKAO’DonnellDEPhysiological changes during symptom recovery from moderate exacerbations of COPDEur Respir J200526342042816135722
  • van GeffenWHDoumaWRSlebosDJKerstjensHABronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPDCochrane Database Syst Rev20168CD01182627569680
  • Lopez-CamposJLAgustiAHeterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposalLancet Respir Med20153972973426165134
  • van GeffenWHBruinsMKerstjensHADiagnosing viral and bacterial respiratory infections in acute COPD exacerbations by an electronic nose: a pilot studyJ Breath Res201610303600127310311
  • van GeffenWHSlebosDJKerstjensHAHyperinflation in COPD exacerbationsLancet Respir Med2015312e43e4426679031
  • MahlerDAO’DonnellDERecent advances in dyspneaChest2015147123224125560861
  • O’DonnellDELavenezianaPThe clinical importance of dynamic lung hyperinflation in COPDCOPD20063421923217361503
  • ShahPLHerthFJvan GeffenWHDesleeGSlebosDJLung volume reduction for emphysemaLancet Respir Med20175214715627693408
  • CooperCBThe connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and functionAm J Med200611910 Suppl 1213116996896
  • RossiAAisanovZAvdeevSMechanisms, assessment and therapeutic implications of lung hyperinflation in COPDRespir Med2015109778580225892293
  • StevensonNJWalkerPPCostelloRWCalverleyPMLung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005172121510151616166620
  • TaubeCLehnigkBPaaschKKirstenDKJorresRAMagnussenHFactor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2000162121622010903244
  • SantusPRadovanovicDHenchiSAssessment of acute bronchodilator effects from specific airway resistance changes in stable COPD patientsRespir Physiol Neurobiol2014197364524726342
  • De BackerJWVosWGGorleCDFlow analyses in the lower airways: patient-specific model and boundary conditionsMed Eng Phys200830787287918096425
  • De BackerJWVosWGVinchurkarSCValidation of computational fluid dynamics in CT-based airway models with SPECT/CTRadiology2010257385486221084417
  • De BackerLAVosWDe BackerJVan HolsbekeCVinchurkarSDe BackerWThe acute effect of budesonide/formoterol in COPD: a multi-slice computed tomography and lung function studyEur Respir J201240229830522183484
  • VosWDe BackerJPoliGNovel functional imaging of changes in small airways of patients treated with extrafine beclomethasone/formoterolRespiration201386539340123595105
  • HajianBDe BackerJVosWVan HolsbekeCClukersJDe BackerWFunctional respiratory imaging (FRI) for optimizing therapy development and patient careExpert Rev Respir Med201610219320626731531
  • VosWHajianBDe BackerJFunctional respiratory imaging to assess the interaction between systemic roflumilast and inhaled ICS/LABA/LAMAInt J Chron Obstruct Pulmon Dis20161126327126917956
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease 20102010 Available from: www.goldcopd.org
  • JonesPWBeehKMChapmanKRDecramerMMahlerDAWedzichaJAMinimal clinically important differences in pharmacological trialsAm J Respir Crit Care Med2014189325025524383418
  • MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
  • van GeffenWHHerthFJDesleeGSlebosDJShahPLLung volume reduction for emphysema – authors’ replyLancet Respir Med201757e2428664863
  • van GeffenWHKerstjensHAMSlebosDJEmerging bronchoscopic treatments for chronic obstructive pulmonary diseasePharmacol Ther20171799610128527920